Products

What will AGI do for Azetirelin?

This classification denotes a thyrotropin-releasing hormone analogue with the molecular formula C15H20N6O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 70J5AWG54Q, chemically known as l-prolinamide, n-((4-oxo-2-azetidinyl)carbonyl)-l-histidyl-, (s)- but generally known as azetirelin, which bears US NIH Compound Identifier 65841. Azetirelin most often comes in base and dihydrate forms. European Medicines Agency schedules Azetirelin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05653MIG. The term AZETIRELIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). AZETIRELIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule azetirelin under HS 29371900 and SITC 54154. As of Q4 2014, AZETIRELIN remains the US FDA Preferred Term for this commodity. Azetirelin bears US NLM identifiers UMLS ID C0285719 and NCI Concept Code C74408. SMILES: O=C(N1C(CCC1)C(=O)N)C(NC(=O)C1NC(=O)C1)CC1[NH]CNC1.